Baird Starts Medpace (MEDP) at Neutral
Get the Pulse of the Market with StreetInsider.com's Pulse Picks. Get your Free Trial here.
Baird initiated coverage on Medpace (NASDAQ: MEDP) with a Neutral rating and a price target of $35.00.
Shares of Medpace closed at $30.70 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Baird Starts Nutanix (NTNX) at Outperform
- Asbury Automotive Group (ABG) PT Lowered to $55 at Jefferies
- Sprint (S) PT Raised to $4.50 at Jefferies